Lung adenocarcinoma with Lambert–Eaton myasthenic syndrome indicated by voltage-gated calcium channel: a case report
Authors:
- Hiromasa AraiHAHiromasa Arai
- Kenji InuiKIKenji Inui
- Kazuki HashimotoKHKazuki Hashimoto
- Kazuki Kan-OKKKazuki Kan-O
- Teppei NishiiTNTeppei Nishii
- Hitaru KishidaHKHitaru Kishida
- Koji OkudelaKOKoji Okudela
- Masahiro TsuboiMTMasahiro Tsuboi
- Akinori NozawaANAkinori Nozawa
- Takeshi KanekoTKTakeshi Kaneko
- Munetaka MasudaMMMunetaka Masuda
Open Access
- 5 September 2012
- journal article
- case report
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 6 (1) , 281
Abstract
Lambert–Eaton myasthenic syndrome is a rare disorder and it is known as a paraneoplastic neurological syndrome. Small cell lung cancer often accompanies this syndrome. Lambert–Eaton myasthenic syndrome associated with lung adenocarcinoma is extremely rare; there are only a few reported cases worldwide. A 75-year-old Japanese man with a past history of chronic rheumatoid arthritis and Sjögren syndrome was diagnosed with Lambert–Eaton myasthenic syndrome by electromyography and serum anti-P/Q-type voltage-gated calcium channel antibody level preceding the diagnosis of lung cancer. A chest computed tomography to screen for malignant lesions revealed an abnormal shadow in the lung. Although a histopathological examination by bronchoscopic study could not reveal the malignancy, lung cancer was mostly suspected after the results of a chest computed tomography and [18F]-fluorodeoxyglucose positron emission tomography. An intraoperative diagnosis based on the frozen section obtained by tumor biopsy was adenocarcinoma so the patient underwent a lobectomy of the right lower lobe and lymph node dissection with video-assisted thoracoscopic surgery. The permanent pathological examination was the same as the frozen diagnosis (pT2aN1M0: Stage IIa: TNM staging 7th edition). Immunohistochemistry revealed that most of the cancer cells were positive for P/Q-type voltage-gated calcium channel. Our case is a rare combination of Lambert–Eaton myasthenic syndrome associated with lung adenocarcinoma, rheumatoid arthritis and Sjögren syndrome, and to the best of our knowledge it is the first report that indicates the presence of voltage-gated calcium channel in lung adenocarcinoma by immunostaining.Keywords
This publication has 12 references indexed in Scilit:
- [Lambert-Eaton myasthenic syndrome].2011
- Adenocarcinoma pulmonar, dermatomiosite e síndrome miastênica de Lambert-Eaton: uma rara associaçãoJornal Brasileiro de Pneumologia, 2008
- The epidemiology of the Lambert-Eaton myasthenic syndrome in the NetherlandsNeurology, 2004
- Seronegative Lambert-Eaton myasthenic syndromeNeurology, 2002
- Lambert-Eaton Myasthenic Syndrome: A Case Report and Review of the LiteratureJournal of Women's Health, 2002
- An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Lambert-Eaton Myasthenic Syndrome Associated with Sjögren's Syndrome and Discoid Lupus ErythematosusScandinavian Journal of Rheumatology, 1993
- A case of Lambert-Eaton myasthenic syndrome associated with adenocarcinoma of the lung.Haigan, 1989
- THE LAMBERT-EATON MYASTHENIC SYNDROMEBrain, 1988
- Myasthenic syndrome (eaton‐lambert syndrome) associated with pulmonary adenocarcinomaJournal of Surgical Oncology, 1987